CoviDx™ SARS-CoV-2 Rapid Antigen Test is a lateral flow assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasal swabs and nasopharyngeal swabs from patients suspected of a Coronavirus-19 (COVID-19) infection by their healthcare provider within the first 5 days of symptoms.

Available in Canada

Doctor cheacking heart beat of patient in bed with stethoscope with nurse adjusting I.V

Benefits of using CoviDx

Rapid Results

Facilitate immediate patient isolation and prioritization of confirmatory testing

Flexible Workflow

Pre-filled extraction vials and individually wrapped reagents enable multiple independent workstations for increased test distribution

Easy-to-use

Instrument-free, user-friendly test procedure for non-lab settings

Convenient

All materials included in the kit for hassle-free logistics

Accurate

100% PPA with PCR for samples with Ct values ≤ 301

SARS-CoV-2 Viral Load Over Course of Infection

Download Sell Sheet

Interested? Contact Us for More Information

Scroll to Top